Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma
Status:
Unknown status
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The investigators aim to demonstrate the efficacy and safety of subconjunctival injection of
Avastin as an adjunctive therapy for Ahmed valve glaucoma implant in patients with refractory
glaucoma.